BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 27605878)

  • 1. Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.
    Åkerberg D; Ansari D; Andersson R
    World J Gastroenterol; 2016 Jul; 22(28):6424-33. PubMed ID: 27605878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future.
    Barhli A; Cros J; Bartholin L; Neuzillet C
    Dig Liver Dis; 2018 Oct; 50(10):979-990. PubMed ID: 30205952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
    Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.
    Williams JL; Nguyen AH; Rochefort M; Muthusamy VR; Wainberg ZA; Dawson DW; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
    J Surg Oncol; 2015 Sep; 112(4):396-402. PubMed ID: 26303811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?
    Buc E; Couvelard A; Kwiatkowski F; Dokmak S; Ruszniewski P; Hammel P; Belghiti J; Sauvanet A
    Eur J Surg Oncol; 2014 Nov; 40(11):1578-85. PubMed ID: 24923739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-year and five-year outcomes of surgical resection for pancreatic ductal adenocarcinoma: Long-term experiences in one medical center.
    Hsu CP; Hsu JT; Liao CH; Kang SC; Lin BC; Hsu YP; Yeh CN; Yeh TS; Hwang TL
    Asian J Surg; 2018 Mar; 41(2):115-123. PubMed ID: 28010955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
    Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
    Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the extent of lymphadenectomy have impact on the prognosis of patients with pancreatic cancer?
    Henne-Bruns D; Vogel I
    Onkologie; 2002 Feb; 25(1):69-71. PubMed ID: 11928695
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas.
    Meyer W; Jurowich C; Reichel M; Steinhäuser B; Wünsch PH; Gebhardt C
    Surg Today; 2000; 30(7):582-7. PubMed ID: 10930222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
    Serrano PE; Cleary SP; Dhani N; Kim PT; Greig PD; Leung K; Moulton CA; Gallinger S; Wei AC
    Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
    Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M
    World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of combined pancreas and portal vein resection in surgery for pancreatic adenocarcinoma.
    Aramaki M; Matsumoto T; Etoh T; Ishio T; Himeno Y; Sasaki A; Yada K; Kawano K; Kitano S
    Hepatogastroenterology; 2003; 50(49):263-6. PubMed ID: 12630036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection.
    Partelli S; Crippa S; Barugola G; Tamburrino D; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
    Ann Surg Oncol; 2011 Dec; 18(13):3608-14. PubMed ID: 21584836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign?
    Belfiori G; Fiorentini G; Tamburrino D; Partelli S; Pagnanelli M; Gasparini G; Castoldi R; Balzano G; Rubini C; Zamboni G; Crippa S; Falconi M
    Surgery; 2021 Feb; 169(2):403-410. PubMed ID: 32912782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma.
    Fukuda S; Oussoultzoglou E; Bachellier P; Rosso E; Nakano H; Audet M; Jaeck D
    Arch Surg; 2007 Feb; 142(2):172-9; discussion 180. PubMed ID: 17309969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute.
    Nanashima A; Tobinaga S; Abo T; Hatano K; Takeshita H; Nonaka T; Hidaka S; Tanaka K; Kunizaki M; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2012 May; 59(115):911-5. PubMed ID: 22469741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis.
    Winter JM; Jiang W; Basturk O; Mino-Kenudson M; Fong ZV; Tan WP; Lavu H; Vollmer CM; Furth EE; Haviland D; Klimstra DS; Jarnagin WR; Lillemoe KD; Yeo CJ; Fernandez-Del Castillo C; Allen PJ
    Ann Surg; 2016 Apr; 263(4):793-801. PubMed ID: 26135696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical therapy of pancreatic cancer - 5 years survival].
    Loveček M; Skalický P; Klos D; Neoral Č; Ehrmann J; Zapletalová J; Švébišová H; Yogeswara T; Ghothim M; Vrba R; Havlík R
    Rozhl Chir; 2015 Nov; 94(11):470-6. PubMed ID: 26766155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting long-term survival following pancreatic resection for ductal adenocarcinoma of the pancreas: 40 years of experience.
    Dusch N; Weiss C; Ströbel P; Kienle P; Post S; Niedergethmann M
    J Gastrointest Surg; 2014 Apr; 18(4):674-81. PubMed ID: 24241965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer.
    Roland CL; Yang AD; Katz MH; Chatterjee D; Wang H; Lin H; Vauthey JN; Pisters PW; Varadhachary GR; Wolff RA; Crane CH; Lee JE; Fleming JB
    Ann Surg Oncol; 2015 Apr; 22(4):1168-75. PubMed ID: 25352267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.